Literature DB >> 21854832

Partial restoration of the long QT syndrome associated KCNQ1 A341V mutant by the KCNE1 β-subunit.

Ikuomi Mikuni1, Carlos G Torres, Martin W Bienengraeber, Wai-Meng Kwok.   

Abstract

BACKGROUND: The A341V mutation in the pore-forming KCNQ1 subunit of the slowly activating delayed-rectifier potassium current (IKs) underlies a common form of the long QT syndrome, and is associated with an unusually severe phenotype. However, there is controversy regarding the underlying mechanism responsible for the clinically observed phenotype. We investigated the biophysical characteristics of A341V in a cardiac environment by utilizing a cardiac cell line, and in particular the impact of the KCNE1 β-subunit.
METHODS: Whole-cell current were recorded from transiently transfected HL-1 cells, a cardiac cell line. Mutant KCNQ1 and KCNE1 were constructed by site-directed mutagenesis.
RESULTS: The A341V mutant resulted in a non-functional channel when expressed alone. When co-expressed with wild type KCNE1, A341V produced a slowly activating current, with a smaller current density, slower rates of activation, and a depolarized shift in its activation curve compared to the wild type KCNQ1+KCNE1. Confocal microscopy confirmed the surface expression of GFP-tagged A341V, suggesting a functionally defective protein. A T58A mutation in KCNE1 abolished functional restoration of A341V. Under heterozygous conditions, the expression of A341V+KCNQ1+KCNE1 reduced but did not abolish the electrophysiological changes observed in A341V+KCNE1. A dominant negative effect of A341V was also observed. Action potential simulations revealed that the A341V mutation is arrhythmogenic.
CONCLUSIONS: The KCNE1 β-subunit partially rescued the non-functional A341V mutant, with electrophysiological properties distinct from the wild type IKs. GENERAL SIGNIFICANCE: The severity of the A341V phenotype may be due to a combination of a significant suppression of the IKs with altered biophysical characteristics. 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21854832      PMCID: PMC3215802          DOI: 10.1016/j.bbagen.2011.07.018

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  40 in total

Review 1.  Molecular and cellular mechanisms of cardiac arrhythmias.

Authors:  M T Keating; M C Sanguinetti
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  KCNE regulation of KvLQT1 channels: structure-function correlates.

Authors:  Yonathan F Melman; Andrew Krummerman; Thomas V McDonald
Journal:  Trends Cardiovasc Med       Date:  2002-05       Impact factor: 6.677

Review 3.  Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function.

Authors:  Steven M White; Phillip E Constantin; William C Claycomb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-03       Impact factor: 4.733

4.  Molecular determinants of KCNQ1 channel block by a benzodiazepine.

Authors:  Guiscard Seebohm; Jun Chen; Nathalie Strutz; Chris Culberson; Christian Lerche; Michael C Sanguinetti
Journal:  Mol Pharmacol       Date:  2003-07       Impact factor: 4.436

5.  KCNE1 binds to the KCNQ1 pore to regulate potassium channel activity.

Authors:  Yonathan F Melman; Sung Yon Um; Andrew Krumerman; Anna Kagan; Thomas V McDonald
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

6.  Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.

Authors:  I Splawski; J Shen; K W Timothy; M H Lehmann; S Priori; J L Robinson; A J Moss; P J Schwartz; J A Towbin; G M Vincent; M T Keating
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

Review 7.  Biology of cardiac arrhythmias: ion channel protein trafficking.

Authors:  Brian P Delisle; Blake D Anson; Sridharan Rajamani; Craig T January
Journal:  Circ Res       Date:  2004-06-11       Impact factor: 17.367

8.  Compound mutations: a common cause of severe long-QT syndrome.

Authors:  Peter Westenskow; Igor Splawski; Katherine W Timothy; Mark T Keating; Michael C Sanguinetti
Journal:  Circulation       Date:  2004-03-29       Impact factor: 29.690

9.  Additional gene variants reduce effectiveness of beta-blockers in the LQT1 form of long QT syndrome.

Authors:  Atsushi Kobori; Nobuaki Sarai; Wataru Shimizu; Yoshihide Nakamura; Yosuke Murakami; Takeru Makiyama; Seiko Ohno; Kotoe Takenaka; Tomonori Ninomiya; Yuichiro Fujiwara; Satoshi Matsuoka; Makoto Takano; Akinori Noma; Toru Kita; Minoru Horie
Journal:  J Cardiovasc Electrophysiol       Date:  2004-02

10.  Pharmacological activation of normal and arrhythmia-associated mutant KCNQ1 potassium channels.

Authors:  Guiscard Seebohm; Michael Pusch; Jun Chen; Michael C Sanguinetti
Journal:  Circ Res       Date:  2003-10-23       Impact factor: 17.367

View more
  6 in total

Review 1.  Voltage-Dependent Gating: Novel Insights from KCNQ1 Channels.

Authors:  Jianmin Cui
Journal:  Biophys J       Date:  2016-01-05       Impact factor: 4.033

2.  Enhanced effects of isoflurane on the long QT syndrome 1-associated A341V mutant.

Authors:  Ikuomi Mikuni; Carlos G Torres; Tania Bakshi; Akihito Tampo; Brian E Carlson; Martin W Bienengraeber; Wai-Meng Kwok
Journal:  Anesthesiology       Date:  2015-04       Impact factor: 7.892

3.  Allosteric mechanism for KCNE1 modulation of KCNQ1 potassium channel activation.

Authors:  Georg Kuenze; Carlos G Vanoye; Reshma R Desai; Sneha Adusumilli; Kathryn R Brewer; Hope Woods; Eli F McDonald; Charles R Sanders; Alfred L George; Jens Meiler
Journal:  Elife       Date:  2020-10-23       Impact factor: 8.140

Review 4.  The membrane protein KCNQ1 potassium ion channel: Functional diversity and current structural insights.

Authors:  Gunjan Dixit; Carole Dabney-Smith; Gary A Lorigan
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-12-09       Impact factor: 3.747

5.  Optical Recording of Action Potentials in Human Induced Pluripotent Stem Cell-Derived Cardiac Single Cells and Monolayers Generated from Long QT Syndrome Type 1 Patients.

Authors:  Tadashi Takaki; Azusa Inagaki; Kazuhisa Chonabayashi; Keiji Inoue; Kenji Miki; Seiko Ohno; Takeru Makiyama; Minoru Horie; Yoshinori Yoshida
Journal:  Stem Cells Int       Date:  2019-03-06       Impact factor: 5.443

6.  Long QT syndrome in South Africa: the results of comprehensive genetic screening.

Authors:  Paula L Hedley; Glenda A Durrheim; Firzana Hendricks; Althea Goosen; Cathrine Jespersgaard; Birgitte Støvring; Tam T Pham; Michael Christiansen; Paul A Brink; Valerie A Corfield
Journal:  Cardiovasc J Afr       Date:  2013-07       Impact factor: 1.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.